Research

Dal researcher Dr. Rita Orji named Fellow of the International Science Council

Dal researcher Dr. Rita Orji named Fellow of the International Science Council

The latest international recognition caps a remarkable stretch of honours and recognition for the Dal computer scientist, who has emerged as a global leader in responsible and human-centred AI.  Read more.

Featured News

Mia Samardzic
Friday, October 23, 2026
The annual Killam Celebration brings together Killam laureates, alumni and their guests to welcome the university鈥檚 newest award recipients and celebrate the lasting impact of the Killam Trusts at 黄色直播.聽
Matt Reeder
Friday, October 9, 2026
As national priorities evolve, Dal researchers, students and partners are contributing expertise, innovation and talent to challenges spanning the ocean, Arctic and beyond.
Matt Reeder
Thursday, October 22, 2026
The latest international recognition caps a remarkable stretch of honours and recognition for the Dal computer scientist, who has emerged as a global leader in responsible and human-centred AI.

Archives - Research

Allison Gerrard
Tuesday, October 4, 2016
The Maritimes have the highest rates of inflammatory bowel disease in the world. Now, Dal's Dr. Tony Otley is set to lead the pediatric component of a five-year, $36-million pan-Canadian gastrointestinal research network.
Michele Charlton
Thursday, September 29, 2016
Bioethicist Fran莽oise Baylis is this year's recipient of the Royal Society of Canada's McNeil Medal, which celebrates outstanding promotion and communication of science to students and the public.
Michele Charlton
Thursday, September 15, 2016
Stan Matwin鈥檚 MERIDIAN project, supported by CFI's Cyberinfrastructure Initiative, will help protect marine species and establish Canada as a global leader in the field of ocean acoustic data.
Allison Gerrard
Tuesday, September 13, 2016
Dal researchers have developed a drug aimed at preventing a rare genetic blinding disease known as "FEVR" that affects children from birth.
Allison Gerrard
Tuesday, September 13, 2016
Atlantic Canada Opportunities Agency announces $3 million in funding to support Dr. Chris McMaster and his team in developing drug treatments for what are known as "orphan" or rare childhood diseases that impact thousands of Canadians.